<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35923692</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-8021</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in genetics</Title><ISOAbbreviation>Front Genet</ISOAbbreviation></Journal><ArticleTitle>Evaluation of a Functional Single Nucleotide Polymorphism of the SARS-CoV-2 Receptor <i>ACE2</i> That Is Potentially Involved in Long COVID.</ArticleTitle><Pagination><StartPage>931562</StartPage><MedlinePgn>931562</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">931562</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2022.931562</ELocationID><Abstract><AbstractText>Since the occurrence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, SARS-CoV-2 has led to a global coronavirus disease 2019 (COVID-19) pandemic. A better understanding of the SARS-CoV-2 receptor <i>ACE2</i> at the genetic level would help combat COVID-19, particularly for long COVID. We performed a genetic analysis of <i>ACE2</i> and searched for its common potential single nucleotide polymorphisms (SNPs) with minor allele frequency &gt;0.05 in both European and Chinese populations that would contribute to <i>ACE2</i> gene expression variation. We thought that the variation of the <i>ACE2</i> expression would be an important biological feature that would strongly affect COVID-19 symptoms, such as "brain fog", which is highlighted by the fact that ACE2 acts as a major cellular receptor for SARS-CoV-2 attachment and is highly expressed in brain tissues. Based on the human GTEx gene expression database, we found rs2106809 exhibited a significant correlation with the <i>ACE2</i> expression among multiple brain and artery tissues. This expression correlation was replicated in an independent European brain eQTL database, Braineac. rs2106809*G also displays significantly higher frequency in Asian populations than in Europeans and displays a protective effect (<i>p</i> = 0.047) against COVID-19 hospitalization when comparing hospitalized COVID-19 cases with non-hospitalized COVID-19 or SARS-CoV-2 test-negative samples with European ancestry from the UK Biobank. Furthermore, we experimentally demonstrated that rs2106809*G could upregulate the transcriptional activity of <i>ACE2</i>. Therefore, integrative analysis and functional experiment strongly support that <i>ACE2</i> SNP rs2106809 is a functional brain eQTL and its potential involvement in long COVID, which warrants further investigation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Luo, Luo, Li, Chen, Wu, Chen, Shen, Li, Guo, Yin, Zhang and Cheng.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yu-Si</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Emergency, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Key and Characteristic Laboratory of Modern Pathogenicity Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Good Clinical Practice Center, Guizhou Provincial People's Hospital, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province, School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Guo-Feng</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Emergency, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Key and Characteristic Laboratory of Modern Pathogenicity Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Hu-Yan</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>The Key and Characteristic Laboratory of Modern Pathogenicity Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hong-Man</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Hypertension, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ming-Yang</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>The Key and Characteristic Laboratory of Modern Pathogenicity Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Sha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Good Clinical Practice Center, Guizhou Provincial People's Hospital, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Key and Characteristic Laboratory of Modern Pathogenicity Biology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Zhong-Shan</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_17228</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_QA137853</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Genet</MedlineTA><NlmUniqueID>101560621</NlmUniqueID><ISSNLinking>1664-8021</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">rs2106809</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>2</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35923692</ArticleId><ArticleId IdType="pmc">PMC9340221</ArticleId><ArticleId IdType="doi">10.3389/fgene.2022.931562</ArticleId><ArticleId IdType="pii">931562</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Letko M., Marzi A., Munster V. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5 (4), 562&#x2013;569. 10.1038/s41564-020-0688-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., Chen H.-D., Chen J., Luo Y., Guo H., Jiang R.-D., Liu M.-Q., Chen Y., Shen X.-R., Wang X., Zheng X.-S., Zhao K., Chen Q.-J., Deng F., Liu L.-L., Yan B., Zhan F.-X., Wang Y.-Y., Xiao G.-F., Shi Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (7798), 270&#x2013;273. 10.1038/s41586-020-2012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., Zhou Y., Du L. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 17 (6), 613&#x2013;620. 10.1038/s41423-020-0400-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0400-4</ArticleId><ArticleId IdType="pmc">PMC7091888</ArticleId><ArticleId IdType="pubmed">32203189</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower M. A., Sarao R., Oudit G. Y., Yagil C., Kozieradzki I., Scanga S. E., Oliveira-dos-Santos A. J., da Costa J., Zhang L., Pei Y., Scholey J., Ferrario C. M., Manoukian A. S., Chappell M. C., Backx P. H., Yagil Y., Penninger J. M. (2002). Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (6891), 822&#x2013;828. 10.1038/nature00786</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V. B., Zhong J.-C., Grant M. B., Oudit G. Y. (2016). Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. Circ Res 118 (8), 1313&#x2013;1326. 10.1161/circresaha.116.307708</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.116.307708</ArticleId><ArticleId IdType="pmc">PMC4939482</ArticleId><ArticleId IdType="pubmed">27081112</ArticleId></ArticleIdList></Reference><Reference><Citation>Miesbach W. (2020). Pathological role of Angiotensin II in severe COVID-19. TH Open 4 (2), e138&#x2013;e44. 10.1055/s-0040-1713678</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1713678</ArticleId><ArticleId IdType="pmc">PMC7319800</ArticleId><ArticleId IdType="pubmed">32607467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W. J., Pogue A., Hill J. M. (2022). SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol 42 (1), 217&#x2013;224. 10.1007/s10571-020-00947-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00947-7</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B.-Z., Chu H., Han S., Shuai H., Deng J., Hu Y.-f., Gong H.-r., Lee A. C.-Y., Zou Z., Yau T., Wu W., Hung I. F.-N., Chan J. F.-W., Yuen K.-Y., Huang J.-D. (2020). SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res 30 (10), 928&#x2013;931. 10.1038/s41422-020-0390-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0390-x</ArticleId><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., L&#xfc;scher T. (2020). COVID-19 is, in the end, an endothelial disease. Eur Heart J 41 (32), 3038&#x2013;3044. 10.1093/eurheartj/ehaa623</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W. W., Li V. W., Mentzer S. J., Jonigk D. (2020). Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 383 (2), 120&#x2013;128. 10.1056/nejmoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. (2022). &#x201c;LONG COVID&#x201d;&#x2014;A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect 10 (1), e00911. 10.1002/prp2.911</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S. J. (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases 53 (10), 737&#x2013;754. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. (2020). A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications. JAMA 324 (22), 2251&#x2013;2. 10.1001/jama.2020.22717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S. J. (2021). Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem. Neurosci. 12 (4), 573&#x2013;580. 10.1021/acschemneuro.0c00793</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. (2021). COVID and the brain: researchers zero in on how damage occurs. Nature 595 (7868), 484&#x2013;485. 10.1038/d41586-021-01693-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01693-6</ArticleId><ArticleId IdType="pubmed">34234323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro D. E., Oliveira-Giacomelli &#xc1;., Glaser T., Arnaud-Sampaio V. F., Andrejew R., Dieckmann L., Baranova J., Lameu C., Ratajczak M. Z., Ulrich H. (2020). Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 26 (4), 1044&#x2013;1059. 10.1038/s41380-020-00965-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00965-3</ArticleId><ArticleId IdType="pmc">PMC7738776</ArticleId><ArticleId IdType="pubmed">33328588</ArticleId></ArticleIdList></Reference><Reference><Citation>The GTEx Consortium (2020). The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369 (6509), 1318&#x2013;1330. 10.1126/science.aaz1776</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz1776</ArticleId><ArticleId IdType="pmc">PMC7737656</ArticleId><ArticleId IdType="pubmed">32913098</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. (2014). Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, 7. 10.1186/s13742-015-0047-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13742-015-0047-8</ArticleId><ArticleId IdType="pmc">PMC4342193</ArticleId><ArticleId IdType="pubmed">25722852</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke L., Zheng-Bradley X, Zheng-Bradley X., Smith R., Kulesha E., Xiao C., Toneva I., Vaughan B., Preuss D., Leinonen R., Shumway M., Sherry S., Flicek P. (2012). The 1000 Genomes Project: data management and community access. Nat Methods 9 (5), 459&#x2013;462. 10.1038/nmeth.1974</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1974</ArticleId><ArticleId IdType="pmc">PMC3340611</ArticleId><ArticleId IdType="pubmed">22543379</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett J. C., Fry B., Maller J., Daly M. J. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2), 263&#x2013;265. 10.1093/bioinformatics/bth457</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bth457</ArticleId><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibord F., Chan M. V., Chen M.-H., Johnson A. D. (2022). A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. Human Genetics and Genomics Advances 3 (2), 100095. 10.1016/j.xhgg.2022.100095</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xhgg.2022.100095</ArticleId><ArticleId IdType="pmc">PMC8863308</ArticleId><ArticleId IdType="pubmed">35224516</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z., Zhou J., To K. K.-W., Chu H., Li C., Wang D., Yang D., Zheng S., Hao K., Boss&#xe9; Y., Obeidat M. e., Brandsma C.-A., Song Y.-Q., Chen Y., Zheng B.-J., Li L., Yuen K.-Y. (2015). Identification ofTMPRSS2as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza. J Infect Dis. 212 (8), 1214&#x2013;1221. 10.1093/infdis/jiv246</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv246</ArticleId><ArticleId IdType="pmc">PMC7107393</ArticleId><ArticleId IdType="pubmed">25904605</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. (2020). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 27 (1), 89&#x2013;95. 10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M. S., Kristiansen M. F., Hanusson K. D., Danielsen M. E., &#xe1; Steig B., Gaini S., Str&#xf8;m M., Weihe P. (2020). Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis 73 (11), e4058&#x2013;e4063. 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X., Wang Y., Sun K., Zhang W., Yang X., Wang S., Zhen Y., Wang J., Li W., Han Y., Liu T., Wang X., Chen J., Wu H., Hui R. (2007). Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women. Clin Pharmacol Ther 82 (2), 187&#x2013;196. 10.1038/sj.clpt.6100214</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.clpt.6100214</ArticleId><ArticleId IdType="pubmed">17473847</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z., Wu G., Yue M., Ye J., Chen Y., Xu B., Shu Z., Zhu J., Lu N., Tan X. (2019). Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism. Life Sciences 225, 39&#x2013;45. 10.1016/j.lfs.2019.03.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.03.059</ArticleId><ArticleId IdType="pubmed">30917908</ArticleId></ArticleIdList></Reference><Reference><Citation>Patnaik M., Pati P., Swain S. N., Mohapatra M. K., Dwibedi B., Kar S. K., Ranjit M. (2013). Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India. Annals of Human Biology 41 (2), 145&#x2013;152. 10.3109/03014460.2013.837195</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03014460.2013.837195</ArticleId><ArticleId IdType="pubmed">24112034</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Chen Y., Zhang P., Zhong J., Jin L., Zhang C., Lin S., Wu S., Yu H. (2016). Association between circulating levels of ACE2-Ang-(1-7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients. Medicine (Baltimore) 95 (24), e3876. 10.1097/md.0000000000003876</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000003876</ArticleId><ArticleId IdType="pmc">PMC4998461</ArticleId><ArticleId IdType="pubmed">27310975</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;elik SK, Gen&#xc7; G&#xc7;, Pi&#x15f;kin N, A&#xe7;ikg&#xf6;z B, Altinsoy B, &#x130;&#x15f;siz BK, et al. (2021). Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study. J Med Virol 93 (10), 5947&#x2013;52. 10.1002/jmv.27160</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27160</ArticleId><ArticleId IdType="pmc">PMC8426884</ArticleId><ArticleId IdType="pubmed">34170561</ArticleId></ArticleIdList></Reference><Reference><Citation>Trump S., Lukassen S., Anker M. S., Chua R. L., Liebig J., Th&#xfc;rmann L., Corman V. M., Binder M., Loske J., Klasa C., Krieger T., Hennig B. P., Messingschlager M., Pott F., Kazmierski J., Twardziok S., Albrecht J. P., Eils J., Hadzibegovic S., Lena A., Heidecker B., B&#xfc;rgel T., Steinfeldt J., Goffinet C., Kurth F., Witzenrath M., V&#xf6;lker M. T., M&#xfc;ller S. D., Liebert U. G., Ishaque N., Kaderali L., Sander L.-E., Drosten C., Laudi S., Eils R., Conrad C., Landmesser U., Lehmann I. (2020). Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol 39 (6), 705&#x2013;716. 10.1038/s41587-020-00796-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-00796-1</ArticleId><ArticleId IdType="pubmed">33361824</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong GU, Lyu J, Kim KD, Chung YC, Yoon GY, Lee S, et al. (2022). SARS-CoV-2 infection of microglia elicits proinflammatory activation and apoptotic cell death. Microbiol Spectr, e0109122. 10.1128/spectrum.01091-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01091-22</ArticleId><ArticleId IdType="pmc">PMC9241873</ArticleId><ArticleId IdType="pubmed">35510852</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>